Alarming gaps in availability of innovative drugs across the EU

Where a cancer patient lives determines whether they have access to life-saving drugs. Investigate Europe research reveals how several EU countries do not have direct access to a number of critical medicines.

13. Juni 2024

Nico Schmidt, Harald Schumann

Pharma firms stash profits in Europe's tax havens as patients struggle with drug prices

Investigate Europe finds 15 of the world’s biggest drugmakers operate more than 1,300 subsidiaries in low-tax territories. These structures helped them amass €580 billion in profits in the past five years. Meanwhile, patients face life-threatening delays for medicines due to high drug prices.

15. Juli 2024

Maxence Peigné

Wie die Pharmaindustrie Europas Arzneimittelbehörde EMA beeinflusst

Investigate Europe has found that the European Medicines Agency is beset by several conflict of interest concerns over professional and financial ties to industry. It is also facing growing criticism for fast-tracking drugs that could pose serious risks to patients.

15. Juli 2024

Maria Maggiore, Leïla Miñano, Manuel Rico, Catrien Spijkerman

Grenzüberschreitende Recherchen aus einem Europa im Wandel, in Ihrem Postfach.

Ausgesuchte Artikel

Unsere Themen


Support cross-border journalism